Dr. Hönle Ag provided earnings guidance for the year 2022/2023 and 2023/2024. The Management Board expected for the Hönle Group, sales of EUR 100 million to EUR 105 million and an operating result (EBIT) between EUR 7 million and EUR 8 million in the 2022/2023 financial year.

For the 2023/2024 financial year the Management Board expects sales of between EUR 105 million and EUR 115 million and an operating result of between EUR 6 million and EUR 9 million for the Hönle Group. All business segments of the Hönle Group are expected to achieve a positive operating result and a positive operating cash flow overall.